首页|基于转录组测序和WGCNA分析挖掘黄芪三七合剂治疗IRI急性肾损伤的关键基因

基于转录组测序和WGCNA分析挖掘黄芪三七合剂治疗IRI急性肾损伤的关键基因

扫码查看
目的:基于高通量转录组测序以及加权基因共表达网络(Weighted gene co-expression network,WGCNA)分析挖掘黄芪三七合剂治疗肾缺血再灌注(IRI)急性肾损伤的关键靶基因。方法:将27只C57BL/6小鼠随机分成假手术对照组、模型对照组和黄芪三七合剂3。9 g/kg组,采用夹闭双侧肾蒂处肾动静脉血管45 min后恢复血供的方法建立急性肾损伤模型。术后给予黄芪三七合剂连续灌胃3 d后检测肾功能、肾脏病理、炎症因子含量等综合评估黄芪三七合剂对IRI急性肾损伤的治疗效果。此外,每组各随机选取3个肾皮质样本,提取总RNA后进行高通量转录组测序。对测序获得的基因表达数据,使用R中的DESeq2包进行差异分析,WGCNA包执行加权基因共表达分析,确定与黄芪三七合剂治疗IRI急性肾损伤相关的共表达模块及关键基因。对挖掘出的关键核心基因进行荧光定量聚合酶链式反应(Real-time PCR)验证。同时,还对共表达模块中的核心基因进行基因本体(GO)和京都基因组百科全书注释系统(KOBAS)通路进行富集分析,描述关键核心基因的生物学功能,以揭示黄芪三七合剂治疗急性肾损伤的可能机制。结果:与模型对照组相比,黄芪三七合剂3。9 g/kg显著降低了 IRI急性肾损伤小鼠血肌酐、尿素氮的含量和肾组织中白细胞介素-1β(Il1b)、Il6和肿瘤坏死因子-α(Tnfa)的mRNA表达(P<0。01),改善肾小管损伤评分。转录组测序差异分析显示,黄芪三七合剂3。9 g/kg组较模型对照组有259个基因发生显著变化,WGCNA分析共获得23个共表达模块,其中黑色共表达模块基因与黄芪三七合剂干预治疗IRI急性肾损伤(IRI。AP)呈显著负相关(r=-0。78,P=7×10-4)。84个黑色共表达模块中的核心基因与黄芪三七合剂3。9 g/kg组较模型对照组的差异基因取交集得到关键核心基因β-1、4-半乳糖基转移酶5(B4galt5)。对黑色共表达模块核心基因进行蛋白质互作网络(PPI)分析得到关键核心蛋白26S蛋白酶体泛素受体(Adrm1)、泛素1(Ubqln1)、蛋白酶体26S亚基泛素受体(Psmd4)、26S蛋白酶体(Psmc2)。两种方法获得的5个关键核心基因的Real-time PCR验证结果与测序结果一致。对黑色共表达模块的核心基因进行GO分析和KOBAS通路富集分析发现关键核心靶点主要与蛋白糖基化修饰和蛋白酶体介导的代谢过程相关。结论:黄芪三七合剂可能通过靶向B4galt5、Adrm1、Ubqln1、Psmd4、Psmc2等关键核心靶点,参与糖基化修饰或蛋白酶体相关代谢途径治疗IRI急性肾损伤。
Key Genes of ASTRAGALI RADIX and NOTOGINSENG RADIX ET RHIZOMA Compounds(AN)in Treating IRI-Induced AKI through RNA-Seq and WGCNA Analysis
Objective:This study aimed to study the key target genes of ASTRAGALI RADIX and NOTOGINSENG RADIX ET RHIZOMA Com-pounds(AN)in treating renal ischemia-reperfusion(IRI)-induced acute kidney injury(AKI)through high-throughput transcriptome se-quencing(RNA-Seq)and weighted gene co-expression network(WGCNA).Methods:A total of 27 C57BL/6 mice were randomly divided into the normal group,model control group,and treatment group(AN of 3.9 g/kg).The AKI model was established by blocking the renal blood supply for 45 minutes followed by reperfusion.After modeling,AN was administrated for three days.The renal function,renal pathologi-cal changes,and contents of inflammatory factors were determined to evaluate the therapeutic effect of AN on IRI-induced AKI.In addition,three randomly selected kidney tissue samples were selected in each group,and total RNA was extracted for high-throughput RNA-Seq.For the gene expression data obtained by RNA-Seq,the DESeq2 package in R was used to analyze the differentially expressed genes(DEGs),and the WGCNA package was used to determine the co-expression modules and key genes closely related to AN treatment of IRI-induced AKI.The screened key genes were verified by real-time polymerase chain reaction(PCR).The key genes in the co-expression module were further subjected to gene ontology(GO)and KEGG orthology-based annotation system(KOBAS)signaling pathway enrichment analysis,so as to de-scribe the biological functions of key genes and reveal the possible mechanism of AN in treating AKI.Results:Compared with the model con-trol group,the treatment group(AN of 3.9 g/kg)significantly reduced the serum levels of creatinine and urea nitrogen and the mRNA expres-sions of interleukin-1 β(Il1β),Il6,and tumor necrosis factor(Tnfα)in renal tissue of mice with IRI-induced AKI(P<0.01)and improved the renal tubular injury.RNA-Seq results showed that compared with the model control group,259 genes changed significantly in the treatment group(AN of 3.9 g/kg).A total of 23 co-expression modules were obtained by WGCNA analysis,among which the black co-expression mod-ule genes were significantly negatively correlated with IRI-induced AKI treated by AN(r=0.78,P=7×10 4).The core genes in the 84 black co-expression modules were intersected with the DEGs of the treatment group(AN of 3.9 g/kg)and the model control group to obtain the key gene,namely B4galt5.The protein-protein interaction(PPI)network analysis of the core protein of the black co-expression modules obtained the key genes including Adrm1,Ubqln1,Psmd4,and Psmc2.The five key genes verified by RT-PCR were consistent with the result of RNA-Seq.GO and KOBAS analysis showed that the key genes were mainly related to protein glycation modification and proteasome-mediated regulated metabolic processes.Conclusion:AN may regulate glycation modification or proteasome-related metabolic pathways to ameliorate IRI-induced AKI by targeting key genes such as B4galt5,Adrm1,Ubqln1,Psmd4,and Psmc2.

ASTRAGALI RADIX and NOTOGINSENG RADIX ET RHIZOMA CompoundsAcute kidney injury(AKI)Renal ischemia-reperfusionRNA-SeqWeighted gene co-expression network(WGCNA)

李玉清、王洪连、胡琼丹、樊均明、王丽

展开 >

西南医科大学中西医结合学院,泸州 646000

西南医科大学附属中医医院中西医结合研究中心,泸州 646000

成都医学院,成都 610500

黄芪三七合剂 急性肾损伤 肾缺血再灌注 转录组测序 加权基因共表达网络分析

四川省科技厅项目泸州市-西南医科大学联合项目泸州市-西南医科大学联合项目

2022YFS06212021LZXNYD-J022021LZXNYD-P04

2024

中药药理与临床
中国药理学会 四川省中医药科学院

中药药理与临床

北大核心
影响因子:0.996
ISSN:1001-859X
年,卷(期):2024.40(2)
  • 20